COMP <GO>
BCPC vs LIN // REVENUE GROWTH (YOY)
Balchem Corporation (NASDAQ) VS. Linde plc (NASDAQ) • 15-METRIC TALLY: BCPC 5
— LIN 7
▲ REVENUE GROWTH (YOY) LEADER: BCPC
LAST: $170.40 (+2.47%) • MKT CAP: $5.41B
revenue-growth
8.80%
LAST: $503.15 (-0.99%) • MKT CAP: $231.94B
revenue-growth
3.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BCPC VS. LIN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BCPC | LIN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 35.70% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.00% | 13.10% | +0.90 | BCPC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 25.5x | 18.5x | +7.00 | LIN | /valuation <GO> |
| Free Cash Flow Yield | 4.00% | 2.19% | +1.81 | BCPC | /fcf-yield <GO> |
| Operating Margin | 20.20% | 26.30% | -6.10 | LIN | /operating-margins <GO> |
| Net Profit Margin | 14.90% | 20.30% | -5.40 | LIN | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 8.80% | 3.00% | +5.80 | BCPC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.52% | 1.21% | -0.69 | LIN | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.67 | 3.93 | +5.74 | BCPC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | BCPC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.4 | 56.6 | -6.17 | LIN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.01 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.6x | 31.2x | +1.40 | LIN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.41B | $231.94B | -$226.53B | LIN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BCPC REV | LIN REV | BCPC GROSS % | LIN GROSS % | BCPC FCF | LIN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.04B | $33.99B | 35.7% | — | $216.6M | $5.09B |
| FY 2024 | $953.7M | $33.01B | 35.3% | — | $182.0M | $4.93B |
| FY 2023 | $922.4M | $32.85B | — | — | $183.8M | $7.83B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BCPC // BETA —
LIN // BETA 1.01